Exhibit 99.3 Investor Presentation November 2024 1 Disclaimer On July 11, 2019 (the "Closing Date"), Thunder Bridge Acquisition Ltd. ("Thunder Bridge") and Hawk Parent Holdings LLC ("Hawk Parent") completed a business combination (the "Business Combination") under which Thunder Bridge acquired Hawk Parent, upon which Thunder Bridge changed its name to Repay Holdings Corporation ("REPAY" or the "Company"). The Company's filings with the Securities and Exchange Commission ("SEC"), which you may obtain for fre ...

a. make it make it amazing | --- | --- | |----------------------------------------------------------------------|-------| | Amdocs Limited | | | | | | | | | NASDAQ: DOX | | | Fiscal Q4 2024 Earnings Presentation November 12, 2024 Shuky Sheffer | | | President & CEO | | | Tamar Rapaport-Dagim | | | CFO & COO | | The information contained herein in this presentation or delivered or to be delivered to you during this presentation does not constitute an offer, expressed or implied, or a recommendation to do any ...

C H E R R Y H I L L L MORTGAGE INVESTMENT CORPORATION Investor Presentation Third Quarter 2024 Legal Disclaimer FORWARD-LOOKING STATEMENTS. Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, references to: potential or expected future cash flows; estimated or expected returns, sometimes referred to as initial IRR, updated IRR, expected IRR, or current-to-maturity IRR; pote ...

| --- | --- | --- | --- | |-------|----------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | Early Intervention with | | | | | Mission for Vision Nasdaq: BLTE an Oral Treatment for Macular Degeneration | | | Forward-Looking Statements and Legal Disclaimer This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or so ...

| --- | --- | |------------------------------------------------|-------| | | | | | | | | | | Investor Overview Q3 2024 Financial Results | | | November 12, 2024 DATE | | Q3 2024 EARNINGS CALL > SAFE HARBOR STATEMENT Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statement ...

Q3 2024 Disclaimer 2 Forward-Looking Statements This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as "will likely result," "are expected to," "will continue," "is antic ...

Crescent Capital BDC, Inc. Quarterly Earnings Presentation September 30, 2024 Disclaimer and Forward-Looking Statement 2 This presentation (the "Presentation") has been prepared by Crescent Capital BDC, Inc. (together with its consolidated subsidiaries, "CCAP," "Crescent BDC" or the "Company") and may be used for informational purposes only. This Presentation contains summaries of certain financial and statistical information about the Company and should be viewed in conjunction with the Company's most rece ...

Supplemental Financial Information For the quarter ended September 30, 2024 November 12, 2024 Corporate Profile And Disclosures Regarding Non-GAAP Financial Measures 2 Comparable Corporate Financial Information 6 Capitalization 12 Property-Level Data And Operating Statistics 15 Property-Level Revenues, Adjusted EBITDAre & Adjusted EBITDAre Margins 20 Supplemental Financial Information November 12, 2024 Table of Contents Supplemental Financial Information November 12, 2024 CORPORATE PROFILE AND DISCLOSURES R ...

9M and Q3 2024 Results Conference call and webcast for investors and analysts 12 November 2024 Forward-looking statements In order, among other things, to utilise the 'safe harbour' provisions of the US Private Securities Litigation Reform Act of 1995, AstraZeneca (hereafter 'the Group') provides the following cautionary statement: This document contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group, including, among other things, stateme ...

The Mosaic Company November 12, 2024 Third Quarter 2024 Results Forward Looking Statements & Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about proposed or pending transactions or strategic plans and other statements about future financial and operating results. Such statements are based upon the current beliefs and expectations of T ...